Abstract
In this paper, a meta-analysis of the effectiveness and safety of intravenous thrombolysis in patients with acute cerebral infarction was carried out, the original literature inclusion criteria and retrieval strategies were developed, and the collection deadline was about new oral anticoagulants and other methods for the antithrombotic intravenous thrombolytic treatment of patients with acute cerebral infarction for the relevant literature on the safety and effectiveness comparison. First, the quality of the literature is evaluated according to whether the included studies are randomized controlled trials, whether there is randomized concealment, whether blinding is used, and whether they are withdrawn or lost to follow-up, and the RevMan 5.2 software is used for meta-analysis. At the same time, grey literature databases such as dissertations were experimentally searched, and all randomized controlled studies (RCT), nonrandomized controlled studies, case-controlled studies, cohort studies, case series reports, etc. of Wingspan in the treatment of intracranial atherosclerotic stenosis were collected. In the prevention of myocardial infarction in patients with acute cerebral infarction, the difference between the two was not statistically significant (RR = 0.82, 95% CI (0.57, 1.17), P = 0.27). Compared with other methods, it can significantly reduce the all-cause mortality of patients with nonvalvular venous thrombolysis, and the difference is statistically significant (RR = 0.90, 95% CI (0.85, 0.96), P = 0.001). Experimental results show that in terms of safety, the new oral anticoagulant is better than other methods in reducing minor bleeding in patients with acute cerebral infarction, and the difference is statistically significant (RR = 0.87, 95% CI (0.76, 0 99), P = 0.03); the effect is better than other methods in reducing the incidence of serious bleeding events, and the difference is statistically significant (RR = 0.79, 95% CI (0.74, 0.85), P < 0.00001).
Highlights
Intravenous thrombolysis is an independent risk factor for acute cerebral infarction
We focus on the effect of repetitive transcranial magnetic stimulation on motor function in patients with acute cerebral infarction in this systematic review and meta-analysis, using the Fugl-Meyer Rating Scale (FMA) scale, grip strength, Jebsen Taylor Hand Function Test Scale (JTHF) hand function test, Pap index/modified, and NIHSS scale as evaluation indexes [11]
This may be due to the higher risk factors for ischemic acute cerebral infarction in men, such as high blood pressure, smoking, coronary artery disease, dyslipidemia, and intravenous thrombolysis
Summary
Intravenous thrombolysis is an independent risk factor for acute cerebral infarction. Foreign clinical trials have demonstrated that new oral anticoagulants are more effective than other methods at reducing severe bleeding in patients receiving nonvalvular intravenous thrombolysis, but they may increase the risk of gastrointestinal bleeding and do not prevent acute cerebral hemorrhage. Computational and Mathematical Methods in Medicine treatment effect on the motor function of patients with acute cerebral infarction It has been confirmed by a number of clinical studies [9]. The results of meta-analysis showed that in terms of effectiveness, new oral anticoagulants were superior to other methods in reducing the incidence of acute cerebral infarction in patients with acute cerebral infarction, and the difference was statistically significant (RR = 0:83, 95% CI (0.71, 0.97), P = 0:02).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
